RF EMerge

A Resource for Innovators

Heading into 2025, patent applicants should prepare for significant fee increases at the United States Patent and Trademark Office (USPTO). These fee increases can significantly impact patent applicant behavior, leading prudent applicants to evaluate and adjust their patent protection strategies.  Pharmaceutical and biotechnology companies in particular should plan and budget for new and drastically increased

BASE Air is a company at the leading edge of safety in the heavy vehicle industry. Founded in 2005 by Matthew Vaughan in Australia, the company focuses on Balance and Safety Enhancement (BASE) for heavy-duty vehicle stability. BASE Air’s technology is a pressure-control system capable of integrating into a vehicle’s existing air suspension, or available

In a long-awaited milestone in the gene therapy space, the Food and Drug Administration (FDA) approved two gene therapies to cure sickle cell disease (SCD).  Soon thereafter these approvals, a key licensing agreement was announced between Vertex and Editas for Cas9 gene editing technology.

Gene therapy is a new type of treatment with the potential

Gene therapy is part of a new wave of medicine that approaches disease treatment by addressing the root causes rather than focusing on treating or reducing symptoms. Currently, gene therapies are being developed for treatment of inherited diseases, autoimmune diseases, cancer, and infectious diseases. In July 2023, we posted about a series of FDA approvals

After decades of intense scientific research into developing gene editing technologies, and more than a few setbacks, the field has produced a number of success stories in recent years, demonstrating that regulatory agencies are increasingly likely to accept safety, efficacy, and durability data to approve such therapies. These advances have culminated in a series of FDA

Guest Post By Leena Chitnis, Founder & CEO, Timberdog®

In today’s fast-paced business environment, intellectual property (IP) has become an invaluable asset for emerging companies. IP refers to the legal rights that are granted to individuals or businesses for their inventions, creations, and innovations. It includes patents, trademarks, copyrights, and trade secrets. Emerging companies

Federal funding is a huge boon for companies, universities, and research institutions conducting innovative research. However, it comes attached with requirements that can become a stumbling block, especially for emerging and smaller companies. Any invention conceived or reduced to practice with the assistance of federal funding is subject to the Bayh-Dole Act, which provides

Gene therapies have been the subject of tremendous scientific research and investment.  With hundreds of clinical trials in progress and many target applications, the biotechnology, agricultural, and pharmaceutical fields are pushing full speed ahead into this promising field.  Helping spur innovations in this field are important issues to be addressed including preventing off-target effects, engineering